Field Trip Health Ltd.
FTRP · NASDAQ
3/31/2022 | 3/31/2021 | 3/31/2020 | |
|---|---|---|---|
| Revenue | $4,860 | $961 | $1 |
| % Growth | 405.8% | 95,989.5% | – |
| Cost of Goods Sold | $9,150 | $1,544 | $9 |
| Gross Profit | -$4,290 | -$583 | -$8 |
| % Margin | -88.3% | -60.7% | -840.3% |
| R&D Expenses | $7,311 | $3,418 | $193 |
| G&A Expenses | $34,483 | $12,059 | $2,628 |
| SG&A Expenses | $37,716 | $13,690 | $2,933 |
| Sales & Mktg Exp. | $3,233 | $1,630 | $306 |
| Other Operating Expenses | $3,709 | $1,338 | $140 |
| Operating Expenses | $48,735 | $18,445 | $3,266 |
| Operating Income | -$53,595 | -$19,029 | -$3,275 |
| % Margin | -1,102.8% | -1,980.3% | -327,500% |
| Other Income/Exp. Net | -$1,096 | -$4,089 | $647 |
| Pre-Tax Income | -$54,691 | -$23,118 | -$2,628 |
| Tax Expense | $1,096 | $0 | $0 |
| Net Income | -$55,787 | -$23,118 | -$2,628 |
| % Margin | -1,147.9% | -2,405.9% | -262,800% |
| EPS | -8.44 | -3.5 | -0.35 |
| % Growth | -141.1% | -900% | – |
| EPS Diluted | -8.44 | -3.5 | -0.35 |
| Weighted Avg Shares Out | 6,614 | 6,614 | 7,597 |
| Weighted Avg Shares Out Dil | 6,614 | 6,614 | 7,597 |
| Supplemental Information | – | – | – |
| Interest Income | $426 | $51 | $3 |
| Interest Expense | $1,096 | $303 | $23 |
| Depreciation & Amortization | $3,603 | $1,394 | $146 |
| EBITDA | -$49,992 | -$21,420 | -$2,459 |
| % Margin | -1,028.6% | -2,229.2% | -245,900% |